• DiscoveryProbe FDA-approved Drug Library: Evidence & Applica

  2026-06-08

  The DiscoveryProbe FDA-approved Drug Library (SKU: L1021) enables high-throughput screening with 2,320 clinically approved compounds. This FDA-approved bioactive compound library accelerates drug repositioning and robust pharmacological target identification in cancer and neurodegenerative disease research.

• LGK-974 (PORCN Inhibitor): Next-Generation Tool for Wnt-Driv

  2026-06-08

  Explore the scientific and translational significance of LGK-974, a potent PORCN inhibitor, for dissecting the Wnt signaling pathway in Wnt-driven cancer models. This article uniquely integrates recent mechanistic insights and rigorous protocol guidance for advanced pancreatic cancer research.

• Nadolol (SQ-11725): Pharmacokinetic Control in Preclinical M

  2026-06-07

  Explore how Nadolol (SQ-11725) advances hypertension research and vascular headache studies by integrating transporter biology and pharmacokinetic insights. This article uniquely bridges tissue distribution mechanisms and assay design for reliable, reproducible results.

• QNZ (EVP4593): Precision NF-κB Modulation in Neuroinflammati

  2026-06-06

  Explore QNZ (EVP4593) as a nanomolar-precision NF-κB pathway inhibitor, with unique insights into its dual anti-inflammatory and neuroprotective actions. This article reveals advanced strategies for integrating QNZ into neurodegenerative disease models, setting it apart from prior reviews.

• Omeprazole (A2845): Technical Guide for Gastric Acid Researc

  2026-06-05

  Omeprazole (SKU A2845) is a research-grade H+,K+-ATPase inhibitor designed for precise modulation of gastric acid secretion in laboratory models. It is best used for studies involving acid-related disorders, peptic ulcer disease models, and antiulcer activity, but is not suitable for diagnostic or clinical applications. Researchers should adhere to strict solubility and stability parameters to ensure data integrity.

• PP 3 as a Negative Control: Refining Src Kinase Pathway Rese

  2026-06-05

  Explore how 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) advances research use only chemical applications in Src kinase signaling. This article reveals unique experimental insights and practical guidance for robust assay development.

• ATS-9R: Precision Gene Silencing in Adipocytes via Prohibiti

  2026-06-04

  ATS-9R (Adipocyte-targeting sequence-9-arginine) enables highly efficient, non-viral gene delivery and silencing in white adipose tissue, leveraging prohibitin-mediated endocytosis for specificity. This guide details optimized experimental workflows, advanced applications in metabolic disease modeling, and troubleshooting strategies to maximize assay reproducibility.

• HyperScript III RT SuperMix: Redefining qPCR for Tumor Immun

  2026-06-04

  Explore how HyperScript III RT SuperMix empowers advanced gene expression and immune profiling in colorectal cancer research. Learn why its unique features enable new assay strategies beyond conventional cDNA synthesis.

• Nuclear Condensate Assembly by Drosophila Keap1 in Oxidative

  2026-06-03

  This study uncovers how Drosophila Keap1 (dKeap1) proteins respond to oxidative stress by assembling nuclear condensates, revealing domain-specific mechanisms underpinning this process. The findings provide new insight into Keap1-Nrf2 pathway regulation and chromatin-associated functions relevant to stress response and development.

• Gasdermin C Drives Stemness and Immune Evasion in PDAC

  2026-06-03

  The reference study uncovers a pyroptosis-independent role for Gasdermin C (GSDMC) in promoting stemness and immune evasion in pancreatic ductal adenocarcinoma (PDAC). By elucidating the nuclear function of cleaved GSDMC, the research identifies new therapeutic targets to enhance treatment response in this highly lethal cancer.

• SAG: Precision Smoothened Agonist for Regeneration & Immunit

  2026-06-02

  This thought-leadership article explores the mechanistic, translational, and strategic role of Smoothened Agonist (SAG) in Hedgehog pathway modulation, highlighting sex-specific immune effects and regenerative applications. It provides protocol guidance, competitive context, and a visionary outlook for advancing myelin repair and neuroprotection.

• Ceftazidime in Respiratory Infection Research: Resistance, M

  2026-06-02

  Explore the scientific foundations of Ceftazidime, a third-generation cephalosporin, and its evolving role in respiratory infection research. This article uniquely synthesizes molecular resistance insights with advanced assay design, offering guidance beyond traditional protocol reviews.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-06-01

  Harper et al. (2025) reveal that inhibition of RNA polymerase II (Pol II) activates a regulated, mitochondria-mediated cell death pathway independently of mRNA transcriptional loss. This study redefines the mechanistic basis of cytotoxicity for transcription-targeting drugs, informing experimental design in DNA damage response and cancer biology research.

• Benzyl Quinolone Carboxylic Acid: Precision in M1 Receptor A

  2026-06-01

  Benzyl Quinolone Carboxylic Acid (BQCA) empowers researchers to dissect and bias M1 muscarinic acetylcholine receptor signaling with unmatched selectivity, enabling robust cognitive and Alzheimer's disease research. This guide translates cutting-edge signaling bias insights into actionable protocols and troubleshooting strategies for high-fidelity neuropharmacology assays.

• Chemistry and Research Applications of Silybin from Milk Thi

  2026-05-31

  The comprehensive review by Křen et al. dissects the chemistry, stereochemistry, and derivatization of silybin, the principal flavonolignan in milk thistle extract. This work establishes the structural basis for silybin’s antioxidant and hepatoprotective properties, informing its application in oxidative stress, cancer, and metabolic disease research.

15862 records 1/1058 page Next 12345 下5页 Last page